
CDC committee votes to resume Johnson & Johnson COVID-19 vaccine despite possible blood clot link
Fox News
A Centers for Disease Control and Prevention (CDC) advisory committee is recommending that the Johnson & Johnson COVID-19 vaccine resume rollout, but include new language on the product’s emergency use authorization (EUA) warning remote risks of serious blood clots.
One committee member abstained. The recommendation will now go before CDC Director Dr. Rochelle Walensky for approval.More Related News













